Latest Content

PARP Inhibitors Help Ovarian Cancer Survivors Live Longer – and Better – Without Disease Progression

October 15th 2021, 7:00pm

By Colleen Moretti

Article

Maintenance therapy with PARP inhibitors may be a beneficial option for patients with ovarian cancer after the first line of treatment.

When Cancer Becomes a Liability in the Relationship

October 15th 2021, 5:00pm

By Jessica Bolz

Article

What do you do when cancer begins to drive a wedge between you and your partner? “I always feel it could cause the end of my relationship because I’m too much,” writes one survivor.

FDA Approves Tecentriq for Pretreated NSCLC

October 15th 2021, 4:21pm

By Brielle Benyon

Article

The Food and Drug Administration approved adjuvant Tecentriq for patients with PD-L1—positive, stage 2 to 3A non-small cell lung cancer.

Rapper Berner Diagnosed With Cancer, Hasbro CEO Dies After Leave of Absence for Cancer Treatment and More

October 15th 2021, 3:00pm

By Jamie Cesanek

Article

From Berner’s cancer diagnosis to lipstick art for cancer fundraising, here’s what’s happening in the cancer landscape this week.

Tremelimumab Plus Imfinzi Regimen Boosts Liver Cancer Survival

October 15th 2021, 2:32pm

By Brielle Benyon

Article

Data from a phase 3 trial show that frontline tremelimumab plus Imfinzi improved overall survival in patients with liver cancer.

Liver Cancer Increasing in Rural Areas of the United States

October 15th 2021, 1:00pm

By Colleen Moretti

Article

The results, according to one of the study’s authors, indicate that liver cancer is an underrecognized and deadly cancer that is increasingly affecting people living in rural areas of the United States.

Individualized Treatment Decisions for Patients With NSCLC

October 15th 2021, 12:02pm

By CURE Media Group

Video

The rationale for waiting on results of molecular testing prior to initiating treatment for patients with non-small cell lung cancer.

Tissue and Liquid Biopsies in NSCLC

October 15th 2021, 12:01pm

By CURE Media Group

Video

The difference between tissue and liquid biopsies used in non-small cell lung cancer, and what patients should know about their results and treatment decision-making.

Trial Initiated to Assess Efficacy of Cosela in Bladder Cancer

October 14th 2021, 11:00pm

By Jamie Cesanek

Article

The PRESERVE 3 trial began this summer to determine efficacy of using Cosela with platinum-based chemotherapy in patients with metastatic bladder cancer.

Cancer Researchers Are Expanding Options for Brain Metastases

October 14th 2021, 9:00pm

By Debu Tripathy, M.D.

Article

Brain metastases are a pattern of spread we are seeing more for many tumor types as patients are living longer with metastatic cancer and we more readily use an array of brain imaging technologies when needed.

Finding New Hope in Triple-Negative Breast Cancer Treatments

October 14th 2021, 7:00pm

By Andy Polhamus

Article

Three therapeutic breakthroughs are revolutionizing care for triple-negative breast cancer and saving women’s lives.

What Do I Say to a Cancer Survivor?

October 14th 2021, 5:00pm

By Jane Biehl Ph.D.

Article

Sometimes cancer survivors do not realize how hard it is for other people to know what to say. We need to educate them!

When the Daughter of a Pediatric Oncologist Receives a Cancer Diagnosis

October 14th 2021, 3:00pm

By Jamie Cesanek

Podcast

“We tried very hard, my daughter and I, to have a daughter-father relationship, not a daughter-doctor relationship,” said Dr. Michael Weiner on this episode of the “CURE® Talks Cancer” podcast, in which he discussed his career, his own cancer journey and his daughter’s diagnosis.

Survival May Be Possible for Patients With CLL Even With Small Amounts of Disease After Treatment

October 14th 2021, 1:00pm

By Darlene Dobkowski, MA

Article

Detectable amounts of minimal residual disease after treatment for CLL does not mean that all hope is lost for survival without disease progression.

Biomarker Testing in Non-Small Cell Lung Cancer

October 14th 2021, 12:03pm

By CURE Media Group

Video

Stephen Liu, MD, and Danielle Hicks describe the purpose and the importance of biomarker testing in non-small cell lung cancer.